Akebia Therapeutics Inc. (AKBA)
NASDAQ · Healthcare
Akebia Therapeutics Inc. Revenue 2014–2025
Akebia Therapeutics Inc. annual/quarterly revenue history and growth rate from 2014 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Akebia Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 53.5 M, a 6.61% decrease year-over-year.
- Akebia Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 232.1 M, a 49.05% increase year-over-year.
- Akebia Therapeutics Inc. annual revenue for 2025 was 236.2 M, a 47.46% increase from 2024.
- Akebia Therapeutics Inc. annual revenue for 2024 was 160.2 M, a 17.70% decrease from 2023.
- Akebia Therapeutics Inc. annual revenue for 2023 was 194.6 M, a 33.46% decrease from 2022.
- Akebia Therapeutics Inc. annual revenue for 2022 was 292.5 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Akebia Therapeutics Inc. Earnings — FAQ
Akebia Therapeutics Inc. (AKBA) earnings over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AKBA's earnings history?
The chart and table above show Akebia Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.